Paris - Delayed Quote EUR
Valneva SE (VLA.PA)
2.7800
-0.0520
(-1.84%)
At close: May 23 at 5:35:07 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
186,057
169,578
153,712
361,303
348,085
Cost of Revenue
99,421
98,538
100,875
324,441
187,920
Gross Profit
86,636
71,040
52,837
36,862
160,165
Operating Expense
147,742
148,809
134,949
150,305
221,514
Operating Income
-61,106
-77,769
-82,112
-113,443
-61,349
Net Non Operating Interest Income Expense
-20,311
-21,622
-22,115
-18,794
-16,714
Other Income Expense
3,255
87,906
5,598
-12,578
8,083
Pretax Income
-78,162
-11,486
-98,629
-144,815
-69,979
Tax Provision
2,227
761
2,800
-1,536
3,446
Net Income Common Stockholders
-80,388
-12,247
-101,429
-143,279
-73,425
Diluted NI Available to Com Stockholders
-80,388
-12,247
-101,429
-143,279
-73,425
Basic EPS
-0.56
-0.08
-0.73
-1.24
-0.75
Diluted EPS
-0.56
-0.08
-0.73
-1.24
-0.75
Basic Average Shares
149,107.6620
145,705.8760
138,943.8360
115,547.5810
97,619.3200
Diluted Average Shares
149,107.6620
145,705.8760
138,943.8360
115,547.5810
97,619.3200
Total Operating Income as Reported
-60,838
13,330
-82,087
-113,443
-61,390
Total Expenses
247,163
247,347
235,824
474,746
409,434
Net Income from Continuing & Discontinued Operation
-80,388
-12,247
-101,429
-143,279
-73,425
Normalized Income
-82,829.2500
-10,051.7500
-105,627.5000
-130,825.5057
-79,369.6800
Interest Income
2,607
2,362
1,210
260
249
Interest Expense
22,918
23,984
23,325
19,054
16,963
Net Interest Income
-20,311
-21,622
-22,115
-18,794
-16,714
EBIT
-55,244
12,498
-75,304
-125,761
-53,016
EBITDA
-55,244
32,084
-57,720
-104,725
-38,735
Reconciled Cost of Revenue
99,421
98,538
100,875
324,441
187,920
Reconciled Depreciation
--
19,586
17,584
21,036
14,281
Net Income from Continuing Operation Net Minority Interest
-80,388
-12,247
-101,429
-143,279
-73,425
Total Unusual Items Excluding Goodwill
3,255
-2,927
5,598
-12,587
8,088
Total Unusual Items
3,255
-2,927
5,598
-12,587
8,088
Normalized EBITDA
-58,499
35,011
-63,318
-92,138
-46,823
Tax Rate for Calcs
0.0003
0.0003
0.0003
0
0.0003
Tax Effect of Unusual Items
813.7500
-731.7500
1,399.5000
-133.5057
2,143.3200
12/31/2021 - 6/29/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GNFT.PA Genfit S.A.
3.8680
-4.59%
DBV.PA DBV Technologies S.A.
1.4960
-3.23%
NANO.PA Nanobiotix S.A.
3.3550
+1.05%
ALBPS.PA Biophytis S.A.
0.1494
+0.95%
ALSEN.PA Sensorion SA
0.3200
-3.03%
ALNEV.PA Neovacs S.A.
0.0050
+4.17%
POXEL.PA Poxel S.A.
0.4390
-3.83%
TNG.PA Transgene SA
0.6100
+8.54%
OSE.PA OSE Immunotherapeutics SA
6.08
-4.48%
SIGHT.PA GenSight Biologics S.A.
0.1900
-2.16%